To the Editor, Philadelphia (Ph) chromosome (t(9; 22)(q34; q11))-positive chronic myeloid leukemia (CML) occurring as a secondary malignancy in patients who were treated for non-Hodgkin lymphoma (NHL) is very rare [1,2]. The association between B-cell–derived lymphoid neoplasias and myeloproliferative disorders is not clear [1]. Until now, CML has been reported after treatment for Hodgkin disease (HD), hairy cell leukemia, or chronic lymphocytic leukemia (CLL). It is not clear whether development of CML as a secondary malignancy represents a therapy-induced complication or possibly a genetic susceptibility to malignancy in which the host may be able to bear 2 different clonal malignanT-cells [3,4]. There is also a possibility that the 2 mal...
Figure 1: Reciprocal translocation between chromosomes 9 and 22 to form the “Philadelphia ” Chromos...
Abstract. Introduction. Imatinib mesylate (IM) remains the treatment of choice for chronic myeloid l...
To the Editor: We share the point that secondary myelodysplasia and secondary acute myelogenous leuk...
The t(9;22)(q34;q11.2) translocation results in a BCR-ABL1 fu-sion gene located on the Philadelphia ...
Although chronic myeloid leukemia (CML) is characterized by the Philadelphia (Ph) chromosome, which ...
the editor: Detection of genetic markers on different populations of hematopoietic progenitor cells ...
CML is a myeloproliferative disease characterized by the Phila-delphia (Ph) chromosome, in which the...
We read with interest the report by Hoyer et al ' describing a series of patients with a leukem...
Therapy-related myeloid neoplasms (t-MN) include myelodys-plastic syndromes (MDS) and acute myeloid ...
Patients with infantile ALL are fundamentally different from adult patients in that infants have a w...
Additional chromosome abnormalities (ACAs) occur in less than 10% of cases at diagnosis of Philadelp...
Treatment of chronic myeloid leukemia (CML) has been profoundly improved by the introduction of tyro...
The authors used cancer registry data to assess the incidence rate of second primary cancers among c...
The BCR-ABL negative chronic myeloproliferative disorders (CMPDs) are a group of stem cell clonal ha...
Introduction. Secondary malignancies, particularly solid tumors, are common in patients with chro...
Figure 1: Reciprocal translocation between chromosomes 9 and 22 to form the “Philadelphia ” Chromos...
Abstract. Introduction. Imatinib mesylate (IM) remains the treatment of choice for chronic myeloid l...
To the Editor: We share the point that secondary myelodysplasia and secondary acute myelogenous leuk...
The t(9;22)(q34;q11.2) translocation results in a BCR-ABL1 fu-sion gene located on the Philadelphia ...
Although chronic myeloid leukemia (CML) is characterized by the Philadelphia (Ph) chromosome, which ...
the editor: Detection of genetic markers on different populations of hematopoietic progenitor cells ...
CML is a myeloproliferative disease characterized by the Phila-delphia (Ph) chromosome, in which the...
We read with interest the report by Hoyer et al ' describing a series of patients with a leukem...
Therapy-related myeloid neoplasms (t-MN) include myelodys-plastic syndromes (MDS) and acute myeloid ...
Patients with infantile ALL are fundamentally different from adult patients in that infants have a w...
Additional chromosome abnormalities (ACAs) occur in less than 10% of cases at diagnosis of Philadelp...
Treatment of chronic myeloid leukemia (CML) has been profoundly improved by the introduction of tyro...
The authors used cancer registry data to assess the incidence rate of second primary cancers among c...
The BCR-ABL negative chronic myeloproliferative disorders (CMPDs) are a group of stem cell clonal ha...
Introduction. Secondary malignancies, particularly solid tumors, are common in patients with chro...
Figure 1: Reciprocal translocation between chromosomes 9 and 22 to form the “Philadelphia ” Chromos...
Abstract. Introduction. Imatinib mesylate (IM) remains the treatment of choice for chronic myeloid l...
To the Editor: We share the point that secondary myelodysplasia and secondary acute myelogenous leuk...